Valera Pharmaceuticals Inc
SEC CIK 1305409 · VLRX · last insider filing 2007-04-19
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dantzker David | Director | filed 2006 - 2007 |
| Feldman Jerome I | Director | filed 2006 - 2007 |
| Reid Ogden R | Director | filed 2006 - 2007 |
| Huckel Hubert E MD | Director | filed 2006 - 2007 |
| Gale James C | Director | filed 2006 - 2007 |
| Spitznagel John T | Director | filed 2006 - 2007 |
| Tierney David S | Director · President and CEO | filed 2006 - 2007 |
| Krauss Jeffrey | Director | filed 2006 - 2007 |
| Silverman Howard | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kuzma Petr F | VP, Research and Development | filed 2006 - 2007 |
| Rue Matthew L III | VP, Marketing | filed 2006 - 2007 |
| Drechsler Andrew T | Chief Financial Officer | filed 2006 - 2007 |
| Middleton Jeremy D | VP, Business Development | filed 2006 - 2007 |
| Perron Pete | VP, Sales | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.